Clinical study of ESWT after meniscus repair

JRCT ID: jRCTs032210145

Registered date:11/06/2021

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Meniscal longitudinal tear
• Date of first enrollment: 11/06/2021
• Target sample size: 16
• Study type: Interventional
• Intervention(s): Extracorporeal shockwave therapy

Outcome(s)

• Primary Outcome: Healing rate on MRI

Secondary Outcome

NRS
Clinical score (KOOS, IKDC score, Lysholme score)
Scientific findings (Ballottement of patella, Range of motion, Mcmurray test, Watson-Johns test, Lachman test, Posterior drawer test)
MRI T2 mapping
Adverse event
Daily use of oral analgesics

Key inclusion & exclusion criteria

• Age minimum: >= 16age old
• Age maximum: Not applicable
• Gender: Both

Include criteria

1) Patients over 16 years old
2) Patients diagnosed with meniscal longitudinal tear by MRI
3) Patients with knee pain above NRS2
4) Patients with PS between 0 and 1
5) Patients who hoped to undergo arthroscopic meniscus repair
6) Patients obtained from consent documents

Exclude criteria

1) Patients who previously underwent therapy for their diseased knee using ESWT
2) Patients with knee osteoarthritis of G3 or higher according to the Kellgren-Lawrence classification
3) Patients with complication of cruciate ligament tear or fracture around knee
4) Patients with previous history of meniscus resection, meniscus repair, cruciate ligament reconstruction or open reduction and internal fixation of bone around knee
5) Patients diagnosed with cognitive decline at the physician's discretion
6) Patients with cotraindication of MRI
7) Patients with open epiphyseal line
8) Patients with untreated blood coagulation disorders such as hemophilia or patients taking anticoagulants
9) Patients with thrombosis
10) Patients with malignant tumor
11) Pregnant woman
12) Patients who have received steroid treatment for 6 months or more, or within 6 weeks after steroid injection
13) Patients judged inappropriate by the doctor

Related Information

• Primary Sponsor: Chikuda Hirotaka